
Supreme Court rejects Eli Lilly's appeal, upholding $194M Medicaid fraud judgment.
The U.S. Supreme Court declined to hear Eli Lilly's appeal, leaving a $194 million whistleblower judgment intact. The case involved allegations that Eli Lilly underreported drug pricing to reduce Medicaid rebate payments by about $61 million. The rul...



